Flatiron Bio
- Biotech or pharma, therapeutic R&D
Flatiron Bio is a promising startup based in the San Francisco Bay Area led by a team of industry and academic experts from Stanford, with a track record of successfully building and exiting previous ventures. Flatiron applies novel mechanistic insights related to the EBV life cycle and its role in driving autoimmune diseases and cancers. Flatiron's lead program is a first-in-class T cell engager targeting a tumor specific EBV viral tumor antigen in late-stage preclinical development.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}